docs will be signed simultaneously with approval
just frustrated... been waiting for this forever. I really thought we would get a ton of upgrades on events and rocket up. Do you think we could base above 40 and make a meaningful move up in the next 30 days ?
1. CANCER DX
A.I'm hearing chatter their new Cancer DX test will be unveiled in Q4.
B: Does it need FDA approval?
C. Has it been approved for reimbursements by health care ?
D. Do they commercial roll-out plan ?
2. BALANCE SHEET
A. BTX is burning 40mm a year and have 31MM in Cash, anyone worried ?
B. An offering could come Sub 2:50 ? or some quasi preferred share deal as they released a few days ago.
Thanks for your time.
Hi Pepsi. I see the ADX is at 25.442 getting higher as 30 usually is showing me a new trend has begun. do you agree with this reading and my analysis. thanks
TTOO is looking very cheap down here for a major disruptive technology that can saves life's and hospitals tons of money..
regarding the offering great question. My gut answer based on experience is that you can never count on a buy out even if its your end game or a viable exit. thus, you need to be prepared for a deal not going , secondly, a depleting war chest can weaken your leverage - stance in a protracted negotiation as the acquiring party can use it against you if when negotiating in good faith. The more i ponder a buy out the more makes it makes sense from a mass global roll out approach. potential candidates , usually suspects all have synergistic tie ins. whether it be relationships with doctors, sales teams, lab scalability and ins with the reimbursers.